FEB 15, 2020 1:57 AM PST

FDA nod for AI-powered technology to detect strokes

WRITTEN BY: Tara Fernandez

The US Food and Drug Administration (FDA) has provided clearance for a novel technology that uses artificial intelligence (AI) to detect strokes. The platform was designed and developed by Aidoc, which has three other FDA-approved systems for diagnosing various acute and chronic conditions in the spine, abdomen, and chest.

The vast majority of strokes are ischaemic, which occurs as a result of a blood clot blocking the flow of blood to the brain. Strokes can also be hemorrhagic in nature when a blood vessel in the brain ruptures. During a stroke, the brain is deprived of oxygen, causing huge numbers of neurons in the affected area to die within minutes. Signs of a stroke include slurred speech, paralysis in one side of the body and loss of coordination.

Elevated blood pressure is a significant risk factor associated with having a stroke, with smoking, obesity, diabetes, and high cholesterol also contributing to an increased risk. In 2015, it was estimated that there were over 42 million stroke survivors worldwide, indicating the sheer extent of the global medical burden from this disease.

Aidoc’s AI-driven system aims to lessen the impact of strokes by diagnosing them faster and more accurately than conventional clinical protocols. Here, the software is capable of identifying both classes of strokes from computerized tomography (CT) scan data, automatically putting suspected cases at the top of radiologists’ worklists, such that medical attention is rendered sooner for these critical patients.

The advent of AI-powered assistive technologies has not always been met with open arms by radiologists and physicians, with many doubting its ability to navigate complex clinical practices and expertise that can only be gained by years of work with patients. However, these platforms are not intended to replace clinical practitioners, but instead to be used as a tool to simplify and accelerate their workloads. Research has found that many radiologists have unrealistic volumes of scans to attend to on a daily basis, requiring them to look at images every three seconds for eight hours a day just to complete their massive quotas.

However, when it comes to strokes, time is of the essence and delayed diagnoses can have permanent, debilitating long-term consequences on patients.

“Stroke is the ultimate time-critical condition. The faster we can identify, diagnose and treat it, the better the outcome for patients,” says Dr. Marcel Maya, co-chair of Cedars-Sinai Medical Center’s Department of Imaging.

Speaking on Aidoc’s diagnostic system he adds, “Aidoc’s comprehensive stroke package flags both large vessel occlusion and hemorrhages inside our existing workflows, ensuring we can diagnose stroke faster and decide on the best course of treatment. We’re already seeing how this has a positive impact on department efficiency and patient length of stay.”

 


Sources: Medical Device Network, Aidoc.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 06, 2020
Clinical & Molecular DX
Your Earwax Says You're Depressed
NOV 06, 2020
Your Earwax Says You're Depressed
Cortisol, commonly known as the “stress hormone”, is the body’s built-in alarm system that sends siren ...
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
DEC 02, 2020
Clinical & Molecular DX
Digital Platform Watches for a Silent COVID Killer
DEC 02, 2020
Digital Platform Watches for a Silent COVID Killer
 
DEC 31, 2020
Clinical & Molecular DX
Silent Mice Drive Autism Gene Discovery
DEC 31, 2020
Silent Mice Drive Autism Gene Discovery
Around 1 in 54 children in the U.S. are diagnosed with autism spectrum disorder, or ASD, a broad range of conditions tha ...
JAN 12, 2021
Clinical & Molecular DX
Portable Sequencer Ensures All the Cancer Cells Are Gone
JAN 12, 2021
Portable Sequencer Ensures All the Cancer Cells Are Gone
Surgeons remove a tumor from the abdominal cavity of a patient. But how can they be certain that all the cancer cells we ...
FEB 09, 2021
Clinical & Molecular DX
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
FEB 09, 2021
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
A clearly defined border differentiates benign tumors from malignant ones. Malignant tumors start to get fuzzy around th ...
Loading Comments...